Common use of DOCUMENTATION AND IDENTIFICATION Clause in Contracts

DOCUMENTATION AND IDENTIFICATION. The GDF Artwork, packaging and labelling guidelines (Annex – GDF Packaging Guidelines – Packaging, Identification and markings of anti-TB medicines) should be used for designing the artwork and labelling of the eligible product. 12.1 The Contractor shall, at its own risk and expense, obtain any export license or other official authorization and carry out all customs formalities necessary for the exportation of the Products. All documents should clearly indicate the IDA Purchase Order number and country of destination. On a case by case basis, if needed the Contractor may request XXX to solicit GDF’s facilitation in the export process by available means in the scope of the procurement services agreement entered between the IDA and the GDF. 12.2 Outer/shipper cartons/tertiary packaging must be clearly labelled as follows: International Non-proprietary Name (INN) or generic name of the FPP, in a bold, clearly visible font size. INNs must not be abbreviated anywhere, including on labels and package inserts, dosage unit (like: 'tablet' etc.), strength/concentration of the product; WHO PQP approval references a) Amount of the active pharmaceutical ingredient (API), using INNs if applicable showing the amount of each present in a dosage unit, and a statement of the container, e.g. number of dosage units, weight or volume. b) Net quantity per unit pack labelled on that unit pack (primary, secondary, tertiary) in a visible manner c) Batch Number assigned by the manufacturer d) Date of manufacturing and date of expiry as MM/YYYY or DD/MM/YYYY;

DOCUMENTATION AND IDENTIFICATION. The GDF Artwork, packaging and labelling guidelines (Annex – GDF Packaging Guidelines – Packaging, Identification and markings of anti-TB medicines) should be used for designing the artwork and labelling of the eligible product. 12.1 The Contractor shall, at its own risk and expense, obtain any export license or other official authorization and carry out all customs formalities necessary for the exportation of the Products. All documents should clearly indicate the IDA XXX Purchase Order number and country of destination. On a case by case basis, if needed the Contractor may request XXX to solicit GDF’s facilitation in the export process by available means in the scope of the procurement services agreement entered between the IDA XXX and the GDF. 12.2 Outer/shipper cartons/tertiary packaging must be clearly labelled as follows: International Non-proprietary Name (INN) or generic name of the FPP, in a bold, clearly visible font size. INNs must not be abbreviated anywhere, including on labels and package inserts, dosage unit (like: 'tablet' etc.), strength/concentration of the product; WHO PQP approval references a) Amount of the active pharmaceutical ingredient (API), using INNs if applicable showing the amount of each present in a dosage unit, and a statement of the container, e.g. number of dosage units, weight or volume. b) Net quantity per unit pack labelled on that unit pack (primary, secondary, tertiary) in a visible manner c) Batch Number assigned by the manufacturer d) Date of manufacturing and date of expiry as MM/YYYY or DD/MM/YYYY;

DOCUMENTATION AND IDENTIFICATION. The GDF Artwork, packaging and labelling guidelines (Annex – GDF Packaging Guidelines – Packaging, Identification and markings of anti-TB medicines) should be used for designing the artwork and labelling of the eligible product. 12.1 The Contractor shall, at its own risk and expense, obtain any export license or other official authorization and carry out all customs formalities necessary for the exportation of the Products. All documents should clearly indicate the IDA XXX Purchase Order number and country of destination. On a case by case basis, if needed the Contractor may request XXX to solicit GDF’s facilitation in the export process by available means in the scope of the procurement services agreement entered between the IDA XXX and the GDF. 12.2 Outer/shipper cartons/tertiary packaging must be clearly labelled as follows: International Non-proprietary Name (INN) or generic name of the FPP, in a bold, clearly visible font size. INNs must not be abbreviated anywhere, including on labels and package inserts, dosage unit (like: 'tablet' etc.), strength/concentration of the product; WHO PQP approval references a) Amount of the active pharmaceutical ingredient (API), using INNs if applicable showing the amount of each present in a dosage unit, and a statement of the container, e.g. number of dosage units, weight or volume. b) Net quantity per unit pack labelled on that unit pack (primary, secondary, tertiary) in a visible manner c) Batch Number assigned by the manufacturer d) Date of manufacturing and date of expiry as MM/YYYY or DD/MM/YYYY;

DOCUMENTATION AND IDENTIFICATION. The GDF Artwork, packaging and labelling guidelines (Annex – GDF Packaging Guidelines – Packaging, Identification and markings of anti-TB medicines) should be used for designing the artwork and labelling of the eligible product. 12.1 The Contractor shall, at its own risk and expense, obtain any export license or other official authorization and carry out all customs formalities necessary for the exportation of the Products. All documents should clearly indicate the IDA Purchase Order number and country of destination. On a case by case basis, if needed the Contractor may request XXX to solicit GDF’s facilitation in the export process by available means in the scope of the procurement services agreement entered between the IDA and the GDF. 12.2 Outer/shipper cartons/tertiary packaging must be clearly labelled as follows: International Non-proprietary Name (INN) or generic name of the FPP, in a bold, clearly visible font size. INNs must not be abbreviated anywhere, including on labels and package inserts, dosage unit (like: 'tablet' etc.), strength/concentration of the product; WHO PQP approval references a) Amount of the active pharmaceutical ingredient (API), using INNs if applicable showing the amount of each present in a dosage unit, and a statement of the container, e.g. number of dosage units, weight or volume. b) Net quantity per unit pack labelled on that unit pack (primary, secondary, tertiary) in a visible manner c) Batch Number assigned by the manufacturer d) Date of manufacturing and date of expiry as MM/YYYY or DD/MM/YYYY;